Related Experiment Video
Updated: Apr 16, 2026

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
Published on: August 12, 2019
Chemokines control mobilization, recruitment, and fate of monocytes in atherosclerosis
Maik Drechsler1, Johan Duchene2, Oliver Soehnlein1
1From the Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany (M.D., J.D., O.S.); Department of Pathology, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands (M.D., O.S.); and German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany (M.D., O.S.). maik.drechsler@med.uni-muenchen.de oliver.soehnlein@gmail.com.
Insights
Chemokines and their receptors control monocyte movement, which is crucial for atherosclerosis development. Understanding this interplay aids in developing treatments for this chronic inflammatory artery disease.
Area of Science:
- Cardiovascular Biology
- Immunology
- Inflammation Research
Background:
- Atherosclerosis is a chronic inflammatory disease affecting large arteries.
- It involves monocyte infiltration, macrophage accumulation, and foam cell formation.
- Chemokines and their receptors are key regulators of immune cell trafficking.
Purpose of the Study:
- To review the current understanding of monocyte-chemokine interactions in atherosclerosis.
- To highlight the role of these interactions in disease development, progression, and regression.
Main Methods:
- Literature review of studies on monocyte trafficking and chemokines in atherosclerosis.
- Synthesis of current knowledge on chemokine receptor signaling in monocytes.
- Analysis of the impact of chemokines on macrophage differentiation and function.
Main Results:
- Chemokines precisely regulate monocyte recruitment to the arterial wall.
- Specific chemokine pathways are critical at different stages of atherosclerosis.
- Targeting chemokine pathways offers potential therapeutic strategies.
Conclusions:
- Monocyte-chemokine axis is central to atherosclerosis pathogenesis.
- Further research into these interactions can reveal novel therapeutic targets.
- Modulating chemokine signaling may impact atherosclerosis progression and regression.
Abstract:
Atherosclerosis is a chronic inflammatory disease of large arteries and, among others, characterized by continuous influx of monocytes into the subendothelial space, subsequent macrophage accumulation, and foam cell formation. Chemokines and their receptors tightly orchestrate monocyte trafficking and fate from birth to death. This brief review summarizes our current understanding of the interplay between monocytes and chemokines entertaining crucial processes in atherosclerosis development, progression, and regression.
More Related Videos
Related Concept Videos
Inflammation
Differentiation of Common Myeloid Progenitor Cells
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction

